U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Tezemlimogene Daxadenorepvec
INN  
Official Name English
tezemlimogene daxadenorepvec [INN]
Common Name English
recombinant conditionally replication-competent oncolytic adenovirus type 5 (Ad5) encoding human immune modulatory protein OX40 ligand (OX40L, CD252, tumor necrosis factor ligand superfamily member 4) under control of the cytomegalovirus (CMV) immediate-
Common Name English
DNA (recombinant human adenovirus 5 ΔE1AΔE3 vector DNX-2440 simian cytomegalovirus immediate-early promoter-enhancer plus human OX40 ligand gene plus Bos taurus growth hormone polyadenylation signal plus viral fiber protein RGD motif insertion mutein-s
Common Name English
DNX-2440
Code English
Code System Code Type Description
INN
12282
Created by admin on Sat Dec 16 18:38:27 GMT 2023 , Edited by admin on Sat Dec 16 18:38:27 GMT 2023
PRIMARY
CAS
2642046-11-3
Created by admin on Sat Dec 16 18:38:27 GMT 2023 , Edited by admin on Sat Dec 16 18:38:27 GMT 2023
PRIMARY
FDA UNII
B7N7BR6M4A
Created by admin on Sat Dec 16 18:38:27 GMT 2023 , Edited by admin on Sat Dec 16 18:38:27 GMT 2023
PRIMARY
NCI_THESAURUS
C160192
Created by admin on Sat Dec 16 18:38:27 GMT 2023 , Edited by admin on Sat Dec 16 18:38:27 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966